The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
The content of the amended complaint from page 53 to page 71 is just concise and direct enough to avoid violating Rule 8,” ...
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback